GlaxoSmithKline (India)

GlaxoSmithKline (India)

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for GlaxoSmithKline (India), India, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

64%


Total
Publications

1.4K


Total Open
Publications

879


Total
Citations

46K


Open Access
Percentage

64%


Total
Publications

1.4K


Total Open
Publications

879


Total
Citations

46K

Wikipedia

Website

download

Breakdown

27% 26% 11% 36%

Publisher Open

27%

Both

26%

Other Platform Open

11%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

24%OA Journal

OA Journal 24%

176

Hybrid 29%

209

No Guarantees 47%

337

Other Platform Open

Domain 77%

392

Institution 28%

142

Preprint 9%

46

Public 7%

38

Other Internet 5%

24

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
388
Europe PMC
Domain
282
Semantic Scholar
Public
34
University College London - UCL Discovery
Institution
26
Research Square
Preprint
24
bioRxiv
Preprint
22
University of Cambridge - Apollo
Institution
16
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
11
University of Dundee - Discovery Research Portal
Institution
11
University of Strathclyde - Strathprints: The University of Strathclyde institutional repository
Institution
9
1 / 11

Data updated 17 June 2024

Share

Share

Share